Affordable Access

New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice.

Authors
Type
Published Article
Journal
Circulation
Publication Date
Volume
103
Issue
16
Pages
2096–2101
Identifiers
PMID: 11319201
Source
Medline
License
Unknown

Abstract

We conclude that this anti-MCP-1 gene therapy may serve not only to reduce atherogenesis but also to stabilize vulnerable atheromatous plaques. This strategy may be a useful and feasible form of gene therapy against atherosclerosis in humans.

Statistics

Seen <100 times